HomeInsightsQuetiapine Drug Interactions: Complete FDA-Data Guide for Patients
Quetiapine

Quetiapine Drug Interactions: Complete FDA-Data Guide for Patients

CDI
CDI Editorial Team
Verified against FDA labeling
📖 5 min read

Quetiapine Drug Interactions: Complete FDA-Data Guide for Patients

What Is Quetiapine and Why Drug Interactions Matter

Quetiapine is an atypical antipsychotic medication prescribed for schizophrenia, bipolar disorder, and major depressive disorder. It works by affecting dopamine and serotonin in the brain. However, quetiapine is metabolized through a specific liver pathway called CYP3A4—meaning dozens of common medications can significantly change how much quetiapine stays in your body.

Too little quetiapine in your system due to drug interactions may reduce its therapeutic benefit. Too much may increase side effects ranging from dizziness and drowsiness to serious cardiac complications. Understanding which drugs interact with quetiapine is essential for safe, effective treatment.

How the FDA Categories These Interactions

The U.S. FDA drug labels for quetiapine identify interaction severity in four tiers: contraindicated (should not be combined), major (significant clinical risk), moderate (mild to moderate clinical effect), and minor (minimal clinical significance). All the interactions covered in this guide are ranked as major by FDA labeling data, meaning they require medical attention, dose adjustment, or careful monitoring.

Major Interactions: CYP3A4 Inhibitors (Drug Metabolism Slowdowns)

CYP3A4 inhibitors are medications or substances that slow the liver's ability to break down quetiapine. This causes quetiapine to accumulate in your bloodstream, leading to higher-than-intended exposure and increased side effects. According to FDA drug labeling, the following are strong or moderate CYP3A4 inhibitors with documented major interactions with quetiapine:

  • Ritonavir (HIV protease inhibitor): A potent CYP3A4 inhibitor that can increase quetiapine exposure dramatically. FDA labeling states that when combined, quetiapine dose must be reduced to one-sixth of the original dose.
  • Ketoconazole (antifungal): Another strong CYP3A4 inhibitor with the same severe interaction profile. Dose reduction to one-sixth is required.
  • Itraconazole (antifungal): Similar mechanism and clinical recommendation: quetiapine dose reduction is necessary.
  • Indinavir (HIV protease inhibitor): Increases quetiapine exposure significantly; dose adjustment required.
  • Nefazodone (antidepressant): A moderate CYP3A4 inhibitor that increases quetiapine levels; dose reduction necessary.

If you take any of these medications alongside quetiapine, do not adjust your dose on your own. Your doctor or pharmacist will calculate the appropriate reduction based on your specific clinical situation.

Major Interactions: CYP3A4 Inducers (Drug Metabolism Speedups)

CYP3A4 inducers do the opposite—they accelerate the liver's breakdown of quetiapine. This can cause quetiapine levels to drop dramatically, reducing its therapeutic benefit. FDA labeling identifies several potent inducers that require up to 5-fold dose increases while taking them, and careful dose reduction upon discontinuation.

  • Carbamazepine (antiseizure): A CYP3A4 inducer that decreases quetiapine exposure; dose adjustment upward is necessary.
  • Phenytoin (antiseizure): A potent inducer that increases quetiapine clearance 5-fold. During chronic use, quetiapine dose may need to increase up to 5-fold. When phenytoin is stopped, quetiapine must be reduced by 5-fold within 7–14 days.
  • Rifampin (antibiotic): A potent inducer with the same severe profile as phenytoin. Dose adjustment up to 5-fold during treatment, reduced 5-fold within 7–14 days of discontinuation.
  • St. John's Wort (herbal supplement): A potent CYP3A4 inducer often overlooked by patients because it is available over-the-counter. It has the same clinical impact as rifampin and phenytoin.

These interactions are particularly complex because stopping or starting these drugs requires coordinated dose adjustment of quetiapine. Sudden dose changes can trigger psychiatric relapse or worsening symptoms if not managed carefully by your healthcare provider.

Major Interaction: Alcohol and Quetiapine

According to FDA drug labeling, alcohol combines with quetiapine to potentiate cognitive and motor effects. This is not a CYP3A4 interaction but rather an additive central nervous system (CNS) depression. The result: increased drowsiness, dizziness, impaired judgment, and reduced coordination.

The FDA label states that alcoholic beverages should be limited while taking quetiapine. This recommendation applies to all patients on quetiapine, not just those at high risk. Heavy or frequent alcohol use alongside quetiapine can significantly impair your ability to think clearly, drive safely, or operate machinery.

Severity and Real-World Risk

All interactions covered here are ranked major, meaning:

  • The interaction can cause clinically significant changes in drug effect or side effect profile.
  • Dose adjustment, timing changes, or alternative medication selection may be necessary.
  • Without adjustment, patients risk either treatment failure or medication toxicity.
  • Ongoing monitoring is required once a dose adjustment is made.

The CYP3A4 interactions are particularly notable because they can shift quetiapine levels by 5-fold or more—a dramatic change that affects safety and efficacy. The alcohol interaction, while not enzyme-based, directly impairs the cognitive and motor function that quetiapine already may affect.

Who Is Most at Risk?

You face elevated interaction risk if you:

Even if you don't fit these categories, always inform your doctor and pharmacist about every medication, supplement, and beverage choice when starting or modifying quetiapine.

What You Should Do

Do not adjust your quetiapine dose on your own. Dose changes must be made by your prescribing physician or under direct pharmacist supervision. Here are evidence-based steps:

  • Before starting or stopping any medication or supplement, inform your doctor and pharmacist that you are taking quetiapine.
  • Disclose all supplements, including St. John's Wort, even though they are available over-the-counter. They are not risk-free.
  • Limit or avoid alcohol. If you drink, discuss frequency and amount with your healthcare provider.
  • Ask specifically about CYP3A4 interactions when a new medication is prescribed. Pharmacists can identify these quickly.
  • Request a medication review from your pharmacist annually or whenever your regimen changes. Professional medication reviews catch interactions that patients and even providers sometimes miss.
  • Monitor your symptoms. If you suddenly feel worse after a new drug is added, or if your psychiatric symptoms return after an existing drug is stopped, contact your prescriber immediately—it may be an interaction.

Bottom Line

Quetiapine is a widely used, effective antipsychotic, but its metabolism through CYP3A4 means it interacts with dozens of common medications and supplements. Major interactions identified in FDA drug labeling include:

These are not rare edge cases. If you take an HIV medication, antifungal, antiseizure drug, or herbal supplement alongside quetiapine, you are experiencing a major interaction that your healthcare team must actively manage.

The most important action you can take is transparency: tell your prescriber and pharmacist about every medication and supplement you use, and ask them directly about quetiapine interactions. Your pharmacist is your best resource for real-time, personalized interaction checking.

Ready to check your full medication list? Visit checkdruginteractions.com—the most comprehensive drug interaction checker on the internet, powered by over 250,000 FDA-labeled drug records. Check up to 20 drugs simultaneously, get instant results, and access our full database with no account needed. Your safety is too important to leave to chance.

Check your medications
Check all your drug interactions at once

CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.

Check now →

Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.

Related Articles